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sso 
baboons that I could see at the time were 
not unduly alarmed at my presence once 
they had reached the top of the cliff. 
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H-2 antigen rt'striction 
of viral infection 
KOSZINOWSKI and Erd demonstrated1 
that T lymphocytes immunised in vivo 
against virus kill virus-infected target 
cells only when these share H-2 antigens 
with the effector cells 2• The commonly 
expressed view 3 is that the effector T cells 
recognise an antigen created by an 
interaction of H-2K or H-2D antigen 
molecules with viral protein. 
To obtain further support for this 
notion, Koszinowski and Erd show 
convincingly that anti-H-2 serum blocks 
killing when it is directed against the 
target cells, but not when directed against 
the effector cells. An unfortunate nomen-
clature (for example, anti-H-2kk for 
(H_2d/k x H_2bb) anti-H-2kk) gives the 
impression that the sera are directed 
against the antigens of the whole H-2 
complex, when in fact both antisera used 
are directed only against the K end of the 
H-2 complex. Thus the H-2D antigens 
of the effector cells are still free, and one 
cannot rule out the alternative hypo-
thesis!, that in order to kill, effector cells 
have to match up their SD antigens with 
those of the targets'. 
On the other hand, cytotoxicity is 
blocked completely whenever the anti-
serum, be it an anti-H-2K or an anti-
vaccinia serum, is directed against the 
target ceHs, and this is taken as evidence 
for an interaction product being the 
target. It is important to know whether 
a similar blocking could be caused by 
any antiserum directed against the target 
cells, or only by anti-H-2 or anti-virus 
serum. Two points are of particular 
interest in this respect. First, blocking 
of cytotoxicity is complete although the 
antisera cover only the K end-if the 
blocking is as specific as in allograft 
reactions, where blocking the target 
antigens of only one end of H-2 hardly 
affects the killing5, this would mean that 
vaccinia, unIike LCM and ectromelia 
virus 2, modifies only the H-2K antigens. 
Second, one should note the blocking of 
F 1 target cells. For example, H-2 k 
effectors do not kill H-2 d targets, but 
they will kill (dx k)F1 as weIl as H-2 k 
target cells. Killing of H-2 k is blocked 
by anti-H-2K\ not by anti-H-2d , while 
killing of F 1 targets are blocked by both 
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antisera. If the H-2 k effectors interact 
only with modified H-2k antigens on the 
target ceIls, one should, again by analogy 
to the specificity in allograft reactions6, 
not have expected anti-H-2d serum to 
have any effect on the killing of F 1 target 
cells by H-2 k effector cells. My comments 
are based on the assumption that complete 
blocking is obtained only when all 
possible effector-target cell interactions 
are inhibited, and I have overinterpreted 
the data, if the relationship between 
percentage 5lCr-release and number of 
lytic interactions is less quantitative. 
Tbe field of T-cell mediated immunity 
to virus infected target cells is fruitful and 
holds promise of information about the 
evolutionary significance of histocom-
patibility antigens3 • It is therefore impor-
tant, before we make conc1usions about 
mechanisms, to know to what extent the 
phenomenon is analogous to allograft 
immunity. 
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KOSZINOWSKI AND ERTL REPLy-We 
think that our data1 do not allow the 
interpretation that serum mediated 
blocking of ceIl-mediated cytolysis (CMC) 
of virus infected syngeneic cells refiects an 
inhibition of all possible effector-target 
cell interactions. We cannot express this 
opinion since we find inhibitory activities 
also with antisera directed against 
vaccinia virus specific surface antigens 2 • 
Tbe F 1 fibroblast targets were extremely 
sensitive for vaccinia infection which led 
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to high spontaneous and small specific 
lysis. We are unsure whether the H-2d 
inhibition in these experiments had a 
significance, since unspecific blocking 
occurred tosomeextent(see Fig.l of ref.l). 
Anyway, xenogenic anti-target cell serum 
absorbed for H-2 had no specific 
inhibitory effect. 
There are indeed indications that, in 
the experimental conditions we used the 
K end is the essential target. When we 
tested an anti-H-2Dk serum «H-2b x 
H-2d) anti-Kd D k ) we found minimal 
blocking activities. 
These resuIts can be explained by two 
possible mechanisms. Vaccinia virus 
alters mainly K-end antigens so that these 
modified antigens can form a target far 
the T cell. On the other hand it is possible 
that T cells predominantly attack K-end 
alterations. Comparable results con-
cerning different inhibitory activity on 
T-cell mediated kiIling by anti-K-end or 
D-end sera have recently been described 
in a tumour situation3 • 
In the ectromelia system some mouse 
strains (BlO.A (2R), BIO.A (4R» react 
more strongly at the K end'. Shearer 
et al. 5 ,6 describe effector cell activity 
against TNP-modified cells absolutely 
restricted to the K end in two mouse 
strains while other strains recognise the 
TNP-modified D end as weIl. Restriction 
of CMC can therefore be dependent on 
the target ceUS,6, the modifying agent and 
the mouse strain used, so that at present 
no generalised answer about K- or 
D-end specificity is possible. 
We think that the intimacy hypothesis7 
of matching unaltered self antigens is 
unlikely. In addition to the arguments of 
Zinkernagel and Doherty8 we found that 
the target antigen in the vaccinia infection 
for the CL has a elose physical relation-
ship to SD antigensi. Second, enzymatic 
reduction of H-2 antigens reduces CMC 
without affecting anti-vaccinia antibody 
media ted cytolysis (Erd and Koszinowski, 
unpublished) and third, expression of the 
H-2 alloantigens is altered detectably by 
reduced serum absorbing capacity and 
inhibited allogenic CMC9,lO. The latter 
observation especiaIly, argues against the 
possibility of matching normal self 
antigens as aprerequisite for the recogni-
tion of new antigenic determinants. 
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